{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T01:48:59Z","timestamp":1772070539883,"version":"3.50.1"},"reference-count":101,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T00:00:00Z","timestamp":1235433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Premature atherosclerosis has been observed during the course of different systemic inflammatory diseases such as rheumatoid arthritis and sytemic lupus erythematosus. Remarkably, relatively few studies have been published on the occurrence of accelerated atherosclerosis in patients with vasculitis. In giant cell arteritis (GCA), mortality because of ischaemic heart disease is not increased. In addition, intima media thickness (IMT) is lower in patients with GCA than in age-matched controls. In contrast, IMT is increased significantly in Takayasu arteritis, another form of large vessel vasculitis occurring in younger patients. In Takayasu arteritis and in Kawasaki disease, a form of medium-sized vessel vasculitis, accelerated atherosclerosis has been well documented. In small vessel vasculitis because of anti-neutrophil cytoplasmic autoantibodies-associated vasculitis, cardiovascular diseases are a major cause of mortality. IMT measurements reveal conflicting results. During active disease these patients experience acceleration of the atherosclerotic process. However, when inflammation is controlled, these patients have atherosclerotic development as in healthy subjects. Several risk factors, such as diabetes and hypertension, are present more often in patients with vasculitis compared with healthy controls. In addition, steroids may be pro-atherogenic. Most importantly, many patients have impaired renal function, persistent proteinuria and increased levels of C-reactive protein, well-known risk factors for acceleration of atherosclerosis. Enhanced oxidation processes, persistently activated T cells and reduced numbers of regulatory T cells are among the many pathophysiological factors that play a role during acceleration of atherogenesis. Finally, autoantibodies that may be relevant for acceleration of atherosclerosis are found frequently in elevated titres in patients with vasculitis. Because patients have an increased risk for cardiovascular events, vasculitis should be treated with as much care as possible. In addition, treatment should be considered with angiotensin-converting-enzyme inhibitors and\/or angiotensin receptor-1 blockers, statins and acetylsalicyl acid. Finally, classical risk factors for cardiovascular disease should be monitored and treated as much as possible.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2009.03885.x","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T10:29:13Z","timestamp":1235471353000},"page":"377-385","source":"Crossref","is-referenced-by-count":65,"title":["Translational Mini-Review Series on Immunology of Vascular Disease: Accelerated atherosclerosis in vasculitis"],"prefix":"10.1093","volume":"156","author":[{"given":"J W","family":"Cohen Tervaert","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,2,24]]},"reference":[{"key":"2021122708535599500_b1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2796.2008.01965.x","article-title":"The molecular mechanisms of the thrombotic complications of atherosclerosis","volume":"263","author":"Libby","year":"2008","journal-title":"J Intern Med"},{"key":"2021122708535599500_b2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2796.2008.01947.x","article-title":"From vulnerable plaque to atherothrombosis","volume":"263","author":"Thim","year":"2008","journal-title":"J Intern Med"},{"key":"2021122708535599500_b3","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"2021122708535599500_b4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2796.2008.01945.x","article-title":"Autoimmunity in atherosclerosis: a protective response losing control?","volume":"263","author":"Nilsson","year":"2008","journal-title":"J Intern Med"},{"key":"2021122708535599500_b5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2796.2008.01944.x","article-title":"Regulatory T-cell immunity and its relevance to atherosclerosis","volume":"263","author":"Taleb","year":"2008","journal-title":"J Intern Med"},{"key":"2021122708535599500_b6","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.CIR.0000143225.07377.EA","article-title":"Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?","volume":"110","author":"Shoenfeld","year":"2004","journal-title":"Circulation"},{"key":"2021122708535599500_b7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2021122708535599500_b8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.berh.2007.05.003","article-title":"Mortality in established rheumatoid arthritis","volume":"21","author":"Naz","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2021122708535599500_b9","first-page":"1495","article-title":"Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis","volume":"35","author":"Peters","year":"2008","journal-title":"J Rheumatol"},{"key":"2021122708535599500_b10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/MOL.0b013e328304b65f","article-title":"Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus","volume":"19","author":"Haque","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"2021122708535599500_b11","article-title":"Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease, a cross sectional study. The CARRE Investigation","author":"Van Halm","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2021122708535599500_b12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"2021122708535599500_b13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am J Med"},{"key":"2021122708535599500_b14","first-page":"713","article-title":"Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964\u201395","volume":"31","author":"Bjornadal","year":"2004","journal-title":"J Rheumatol"},{"key":"2021122708535599500_b15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2796.2005.01502.x","article-title":"SLE, atherosclerosis and cardiovascular disease","volume":"257","author":"Frostegard","year":"2005","journal-title":"J Intern Med"},{"key":"2021122708535599500_b16","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation"},{"key":"2021122708535599500_b17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ncprheum0178","article-title":"Therapy insight: managing cardiovascular risk in patients with rheumatoid arthritis","volume":"2","author":"Giles","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2021122708535599500_b18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2008.08.004","article-title":"Cardiovascular involvement in systemic autoimmune diseases","volume":"8","author":"Sitia","year":"2009","journal-title":"Autoimmun Rev"},{"key":"2021122708535599500_b19","article-title":"Translational Mini-Review Series on Immunology of Vascular Disease: Mechanisms of vascular inflammation and remodelling in systemic vasculitis","author":"Maugeri","journal-title":"Clin Exp Immunol"},{"key":"2021122708535599500_b20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2021122708535599500_b21","volume-title":"Standard therapeutic regimens for vasculitis","author":"Cohen Tervaert","year":"2001"},{"key":"2021122708535599500_b22","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021122708535599500_b23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9343(97)89458-2","article-title":"Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort","volume":"100","author":"Matteson","year":"1996","journal-title":"Am J Med"},{"key":"2021122708535599500_b24","first-page":"2171","article-title":"Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality","volume":"24","author":"Gonzalez-Gay","year":"1997","journal-title":"J Rheumatol"},{"key":"2021122708535599500_b25","first-page":"502","article-title":"Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"J Rheumatol"},{"key":"2021122708535599500_b26","first-page":"74","article-title":"Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis","volume":"33","author":"Gonzalez-Juanatey","year":"2006","journal-title":"J Rheumatol"},{"key":"2021122708535599500_b27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/art.22546","article-title":"Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality?","volume":"57","author":"Gonzalez-Gay","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021122708535599500_b28","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.23114","article-title":"Atherosclerosis in patients with biopsy-proven giant cell arteritis","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021122708535599500_b29","first-page":"2752","article-title":"Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage","volume":"28","author":"Filer","year":"2001","journal-title":"J Rheumatol"},{"key":"2021122708535599500_b30","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/ard.2005.047498","article-title":"Atherosclerosis in Takayasu arteritis","volume":"65","author":"Seyahi","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2021122708535599500_b31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.autrev.2007.04.001","article-title":"Coronary involvement in Takayasu\u2019s arteritis","volume":"6","author":"Rav-Acha","year":"2007","journal-title":"Autoimmun Rev"},{"key":"2021122708535599500_b32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(00)02701-X","article-title":"Takayasu\u2019s arteritis","volume":"356","author":"Numano","year":"2000","journal-title":"Lancet"},{"key":"2021122708535599500_b33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/03009740252937595","article-title":"Carotid and femoral artery stiffness in Takayasu\u2019s arteritis. An ultrasound study","volume":"31","author":"Raninen","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"2021122708535599500_b34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1542\/peds.107.5.1095","article-title":"Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions","volume":"107","author":"Noto","year":"2001","journal-title":"Pediatrics"},{"key":"2021122708535599500_b35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/adc.2006.096628","article-title":"Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease","volume":"92","author":"Cheung","year":"2007","journal-title":"Arch Dis Child"},{"key":"2021122708535599500_b36","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00246-005-0921-8","article-title":"Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease","volume":"26","author":"Ikemoto","year":"2005","journal-title":"Pediatr Cardiol"},{"key":"2021122708535599500_b37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpeds.2007.03.056","article-title":"Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?","volume":"151","author":"McCrindle","year":"2007","journal-title":"J Pediatr"},{"key":"2021122708535599500_b38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1196\/annals.1381.027","article-title":"Type II cryoglobulinemia is not associated with hepatitis C infection: the Dutch experience","volume":"1107","author":"Cohen Tervaert","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"2021122708535599500_b39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1994.239","article-title":"Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential","volume":"46","author":"Kallenberg","year":"1994","journal-title":"Kidney Int"},{"key":"2021122708535599500_b40","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/ndt\/15.10.1593","article-title":"Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study","volume":"15","author":"Hedger","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"2021122708535599500_b41","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1097\/01.ASN.0000093256.18266.22","article-title":"High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement","volume":"14","author":"Westman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2021122708535599500_b42","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/ndt\/13.7.1696","article-title":"Has the prognosis for patients with pauci-immune necrotizing glomerulonephritis improved?","volume":"13","author":"McLaughlin","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"2021122708535599500_b43","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.V971258","article-title":"Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"9","author":"Allen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2021122708535599500_b44","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","article-title":"Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg\u2013Strauss syndrome: analysis of four prospective trials including 278 patients","volume":"44","author":"Gayraud","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2021122708535599500_b45","first-page":"243","article-title":"Crescentic glomerulonephritis in Wegener\u2019s granulomatosis: morphology, therapy, outcome","volume":"35","author":"Grotz","year":"1991","journal-title":"Clin Nephrol"},{"key":"2021122708535599500_b46","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1523-1755.2003.00769.x","article-title":"Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement","volume":"63","author":"Slot","year":"2003","journal-title":"Kidney Int"},{"key":"2021122708535599500_b47","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1681\/ASN.V9101915","article-title":"Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis","volume":"9","author":"Franssen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2021122708535599500_b48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ndt\/15.5.611","article-title":"Wegener\u2019s granulomatosis: clinical course in 108 patients with renal involvement","volume":"15","author":"Aasarod","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"2021122708535599500_b49","first-page":"S35","article-title":"Accelerated atherosclerosis in Wegener\u2019s granulomatosis (WG): a sonographic case\u2013control study on intima media thickness","volume":"46","author":"Zaenker","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2021122708535599500_b50","first-page":"282","article-title":"Cardiovascular disease incidence and risk factors in ANCA-associated primary systemic vasculitis (AASV)","volume":"26","author":"McLaren","year":"2003","journal-title":"Kidney Bloodpressure Res"},{"key":"2021122708535599500_b51","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/ard.2004.029033","article-title":"Accelerated atherosclerosis in patients with Wegener\u2019s granulomatosis","volume":"64","author":"De Leeuw","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2021122708535599500_b52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/hrt.2006.088443","article-title":"Increased prevalence of subclinical atherosclerosis in patients with small-vessel vasculitis","volume":"93","author":"Chironi","year":"2007","journal-title":"Heart"},{"key":"2021122708535599500_b53","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/01.CIR.102.13.1470","article-title":"Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?","volume":"102","author":"Raza","year":"2000","journal-title":"Circulation"},{"key":"2021122708535599500_b54","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.0000124720.18538.DD","article-title":"Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation","volume":"109","author":"Booth","year":"2004","journal-title":"Circulation"},{"key":"2021122708535599500_b55","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/030097497199712063049","article-title":"Enhanced endothelium-dependent vasodilator responses in patients with systemic vasculitis","volume":"26","author":"Bruce","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"2021122708535599500_b56","first-page":"1875","article-title":"Enhanced endothelium-dependent microvascular responses in patients with Wegener\u2019s granulomatosis","volume":"34","author":"Nienhuis","year":"2007","journal-title":"J Rheumatol"},{"key":"2021122708535599500_b57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.20002","article-title":"Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation","volume":"50","author":"Booth","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2021122708535599500_b58","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/rheumatology\/ken155","article-title":"Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis","volume":"47","author":"Sangle","year":"2008","journal-title":"Rheumatology (Oxf)"},{"key":"2021122708535599500_b59","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/art.23561","article-title":"Effects of glucocorticoids on weight change during the treatment of Wegener\u2019s granulomatosis","volume":"59","author":"Wung","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2021122708535599500_b60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. The road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"2021122708535599500_b61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00002281-199701000-00004","article-title":"Cell adhesion molecules in vasculitis","volume":"9","author":"Tervaert","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"2021122708535599500_b62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0049-0172(97)80010-8","article-title":"Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies","volume":"27","author":"Belizna","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"2021122708535599500_b63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2005.11.101","article-title":"Role of C-C chemokines in Takayasu\u2019s arteritis disease","volume":"112","author":"Dhawan","year":"2006","journal-title":"Int J Cardiol"},{"key":"2021122708535599500_b64","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2249.2005.02770.x","article-title":"Increased expression of chemokines in patients with Wegener\u2019s granulomatosis \u2013 modulating effects of methylprednisolone in vitro","volume":"140","author":"Torheim","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"2021122708535599500_b65","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/ard.59.10.775","article-title":"Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica","volume":"59","author":"Ellingsen","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"2021122708535599500_b66","first-page":"1179","article-title":"Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease","volume":"24","author":"Wong","year":"1997","journal-title":"J Rheumatol"},{"key":"2021122708535599500_b67","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/rheumatology\/kel128","article-title":"Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis","volume":"45","author":"Cid","year":"2006","journal-title":"Rheumatology (Oxf)"},{"key":"2021122708535599500_b68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.dld.2008.04.009","article-title":"CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C","volume":"41","author":"Antonelli","year":"2009","journal-title":"Dig Liver Dis"},{"key":"2021122708535599500_b69","article-title":"Translational Mini-Review Series on Immunology of Vascular Disease: Inflammation, infections and Toll-like receptors in cardiovascular disease","author":"Ward","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2021122708535599500_b70","first-page":"SII24","article-title":"Infections in primary vasculitides","volume":"69","author":"Tervaert","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"2021122708535599500_b71","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/JVI.77.8.4588-4596.2003","article-title":"Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2","volume":"77","author":"Compton","year":"2003","journal-title":"J Virol"},{"key":"2021122708535599500_b72","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/ATVBAHA.107.154807","article-title":"Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-\/- mice","volume":"28","author":"Van Leeuwen","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021122708535599500_b73","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCRESAHA.107.160697","article-title":"Protective role of CXC receptor 4\/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis","volume":"102","author":"Zernecke","year":"2008","journal-title":"Circ Res"},{"key":"2021122708535599500_b74","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.it.2005.08.010","article-title":"Anti-neutrophil cytoplasmic autoantibodies and leukocyte\u2013endothelial interactions: a sticky connection?","volume":"26","author":"Heeringa","year":"2005","journal-title":"Trends Immunol"},{"key":"2021122708535599500_b75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9440(10)62951-3","article-title":"The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies","volume":"167","author":"Xiao","year":"2005","journal-title":"Am J Pathol"},{"key":"2021122708535599500_b76","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0891-5849(02)01294-7","article-title":"Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor","volume":"34","author":"Podrez","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"2021122708535599500_b77","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbalip.2006.03.024","article-title":"Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid","volume":"1761","author":"Malle","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"2021122708535599500_b78","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00041433-200308000-00003","article-title":"Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment","volume":"14","author":"Brennan","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"2021122708535599500_b79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2007.03.033","article-title":"Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study","volume":"50","author":"Meuwese","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2021122708535599500_b80","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJM200401293500519","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"350","author":"Asselbergs","year":"2004","journal-title":"N Engl J Med"},{"key":"2021122708535599500_b81","first-page":"S55","article-title":"The role of myeloperoxidase in the pathogenesis of systemic vasculitis","volume":"21","author":"Rutgers","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2021122708535599500_b82","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/030097499442559","article-title":"Circulating myeloperoxidase and anti-myeloperoxidase antibody in patients with vasculitis","volume":"28","author":"Minota","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"2021122708535599500_b83","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/clim.2002.5206","article-title":"463 G\/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis","volume":"103","author":"Reynolds","year":"2002","journal-title":"Clin Immunol"},{"key":"2021122708535599500_b84","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2249.2007.03418.x","article-title":"Meta-analysis of myeloperoxidase G-463\/A polymorphism in anti-neutrophil cytoplasmic autoantibody-positive vasculitis","volume":"149","author":"Rajp","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2021122708535599500_b85","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.20030850","article-title":"Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis","volume":"199","author":"Ma-Krupa","year":"2004","journal-title":"J Exp Med"},{"key":"2021122708535599500_b86","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ndt\/gfn461","article-title":"CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener\u2019s granulomatosis","volume":"24","author":"Wilde","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2021122708535599500_b87","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clim.2008.03.506","article-title":"Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis","volume":"128","author":"Slot","year":"2008","journal-title":"Clin Immunol"},{"key":"2021122708535599500_b88","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.101.25.2883","article-title":"T-cell proliferation and plaque instability in acute coronary syndromes","volume":"101","author":"Liuzzo","year":"2000","journal-title":"Circulation"},{"key":"2021122708535599500_b89","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2796.2006.01698.x","article-title":"Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener\u2019s granulomatosis","volume":"260","author":"Lamprecht","year":"2006","journal-title":"J Intern Med"},{"key":"2021122708535599500_b90","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/art.22692","article-title":"Functional defect of circulating regulatory CD4+ T cells in patients with Wegener\u2019s granulomatosis in remission","volume":"56","author":"Abdulahad","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021122708535599500_b91","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jaci.2008.05.040","article-title":"Differences in regulatory T cells between Churg\u2013Strauss syndrome and chronic eosinophilic pneumonia with asthma","volume":"122","author":"Tsurikisawa","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"2021122708535599500_b92","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/art.23759","article-title":"Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis","volume":"58","author":"Landau","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2021122708535599500_b93","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2249.2001.01488.x","article-title":"Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL","volume":"124","author":"Swets","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"2021122708535599500_b94","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2249.2007.03420.x","article-title":"Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins","volume":"149","author":"Slot","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2021122708535599500_b95","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/01.CIR.100.11.1169","article-title":"Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study","volume":"100","author":"Xu","year":"1999","journal-title":"Circulation"},{"key":"2021122708535599500_b96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000237318","article-title":"Increased antibody titers against mycobacterial heat-shock protein 65 in patients with vasculitis and arteriosclerosis","volume":"110","author":"Gruber","year":"1996","journal-title":"Int Arch Allergy Immunol"},{"key":"2021122708535599500_b97","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1740-2557-3-4","article-title":"Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study","volume":"3","author":"Slot","year":"2006","journal-title":"J Autoimmune Dis"},{"key":"2021122708535599500_b98","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.CIR.97.9.900","article-title":"Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome","volume":"97","author":"George","year":"1998","journal-title":"Circulation"},{"key":"2021122708535599500_b99","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1161\/01.CIR.102.15.1822","article-title":"Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice","volume":"102","author":"George","year":"2000","journal-title":"Circulation"},{"key":"2021122708535599500_b100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/sarh.2001.23499","article-title":"Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis","volume":"31","author":"Espinosa","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"2021122708535599500_b101","first-page":"2446","article-title":"The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener\u2019s granulomatosis with and without history of a thrombotic event","volume":"34","author":"Sebastian","year":"2007","journal-title":"J Rheumatol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2009.03885.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/156\/3\/377\/41926991\/j.1365-2249.2009.03885.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/156\/3\/377\/41926991\/j.1365-2249.2009.03885.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:24:49Z","timestamp":1641054289000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/156\/3\/377\/6425449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,24]]},"references-count":101,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,2,24]]},"published-print":{"date-parts":[[2009,5,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2009.03885.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,6]]},"published":{"date-parts":[[2009,2,24]]}}}